RAGE: A potential therapeutic target during FGF1 treatment of diabetes-mediated liver injury.
Zheng P, Tang Z, Xiong J, Wang B, Xu J, Chen L, Cai S, Wu C, Ye L, Xu K, Chen Z, Wu Y, Xiao J.
Zheng P, et al.
J Cell Mol Med. 2021 May;25(10):4776-4785. doi: 10.1111/jcmm.16446. Epub 2021 Mar 31.
J Cell Mol Med. 2021.
PMID: 33788387
Free PMC article.